<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QPA-T-IGAD-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>TB Interventions among refugees in Eastern Africa - Eastern Africa - Multicountry Eastern Africa IGAD (01-Apr-2019-31-Mar-2022)</narrative>
    </title>
    <description type="1">
      <narrative>Multicountry Eastern Africa IGAD, Tuberculosis, Intergovernmental Authority on Development</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To contribute to ending TB  in the IGAD region. Objectives: To strengthen capacity for TB and MDR-TB diagnosis and TB (TB/HIV) service provision in the refugee camps including cross border health facilities; To strengthen in-country and cross border collaboration of NTPs/NAPs for improved TB (and TB/HIV) service provision among refugees; To address policy barriers and related national support to TB and MDR-TB services for refugees in the region.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="40000">
      <narrative>Intergovernmental Authority on Development</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="40000">
      <narrative>Intergovernmental Authority on Development</narrative>
    </participating-org>
    <other-identifier ref="QPA-T-IGADP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-04-01" />
    <activity-date type="2" iso-date="2019-04-01" />
    <activity-date type="3" iso-date="2022-03-31" />
    <activity-date type="4" iso-date="2022-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>George Sakvarelidze</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>george.sakvarelidze@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="3" />
    <recipient-region code="MCIGAD" vocabulary="99" vocabulary-uri="https://fetch.theglobalfund.org/v5/odata/geographies" percentage="100">
      <narrative>Multicountry Eastern Africa IGAD</narrative>
    </recipient-region>
    <sector vocabulary="1" code="12263" percentage="52.33">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="47.67">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="8.52">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="36.35">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="1.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="8478da1e-4bf9-41c9-b50a-39121b1476eb" percentage="1.7">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service organization and facility management</narrative>
        </description>
      </budget-item>
      <budget-item code="43569924-d9cb-4e7a-90e7-975fd08c02de" percentage="9.19">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="4.49">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="38.4">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="0.24">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">1952869.81</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">2446758.97</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">4122398.24</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">407973.34</value>
    </budget>
    <capital-spend percentage="2.72" />
    <transaction ref="c57e9605-e75b-446e-9891-5fbbc70b34fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-20" />
      <value currency="USD" value-date="2019-06-20">3529165.00</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6f0168ae-d92e-4c22-afb0-b35274a7df4c">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-25" />
      <value currency="USD" value-date="2019-06-25">279137.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="81e5cb8d-dfbf-48cf-bc22-03675da11e26">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-06" />
      <value currency="USD" value-date="2019-09-06">523000.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b464594a-a91a-4942-a20e-93d5fe0247bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-06" />
      <value currency="USD" value-date="2019-09-06">690085.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3fc066f8-fc06-42b7-b8c8-ba1ece9ce60a">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-12" />
      <value currency="USD" value-date="2019-11-12">429113.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a085af20-7362-4892-852d-825a797cec43">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-16" />
      <value currency="USD" value-date="2020-04-16">969743.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="72b05d64-6063-425d-bb9d-f64bf6bb9004">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">307332.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="84229835-4847-41b0-bfbd-72cadb4133e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-16" />
      <value currency="USD" value-date="2020-06-16">117147.59</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9ddf6f7a-b9c2-484a-b47d-90fe22396093">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-09-18" />
      <value currency="USD" value-date="2020-09-18">-213607.41</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b0cd5f1e-bda1-4e12-9234-0369173cf160">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-09-18" />
      <value currency="USD" value-date="2020-09-18">2464203.55</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="28832c68-263b-46d6-8442-572fcc800de0">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-23" />
      <value currency="USD" value-date="2020-09-23">1363423.01</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6f8ca10-fcbd-48b0-8d80-2d5a5d80ce02">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-22" />
      <value currency="USD" value-date="2020-12-22">334249.22</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="08ca4d31-7881-4345-b2b2-08ee4b9f8e64">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-02" />
      <value currency="USD" value-date="2021-07-02">2215127.03</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="33f0cdb5-9737-4929-9140-1f51f7788539">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-02" />
      <value currency="USD" value-date="2021-07-02">-766531.32</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="104bef3f-d3aa-4d94-8fe8-b9c9abdda234">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-08" />
      <value currency="USD" value-date="2021-07-08">852475.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="20d98339-105b-4aa9-b37f-998edc496991">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-12" />
      <value currency="USD" value-date="2021-08-12">578867.64</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="38e49903-499d-46cc-9560-698fc2368436">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-25" />
      <value currency="USD" value-date="2021-11-25">479396.26</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0890c092-153f-4000-844c-5b55906db3c5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">338777.00</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9cf862f6-1697-4d06-b885-6dc978ed5eb5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">-304388.13</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="81e50a48-2028-46bf-85ae-61c3dce25014">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">338777.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="QPA-T-IGADP01-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">1507983.67</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP01, Apr 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QPA-T-IGADP01-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">2248267.69</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP01, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QPA-T-IGADP01-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">2814228.09</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP01, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QPA-T-IGADP01-EXP-20220331">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-03-31" />
      <value currency="USD" value-date="2022-03-31">764744.35</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP01, Jan 2022 to Mar 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QPA-T-IGAD" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 34.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 34; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 34; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 34; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 34; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9; Percentage: 0.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3; Percentage: 0.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3; Percentage: 0.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3; Percentage: 0.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3; Percentage: 0.25%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 26; Denominator: 28; Percentage: 92.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 28; Percentage: 7.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10; Denominator: 28; Percentage: 35.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 18; Denominator: 28; Percentage: 64.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 15.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 7; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1; Denominator: 7; Percentage: 14.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 6; Denominator: 7; Percentage: 85.71%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 2207.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 492.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 492.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 492.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 492.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1276.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1276.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1276.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1276.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1291.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1291.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1291.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1291.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 911.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 911.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 911.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 911.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1933.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1933.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1933.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1933.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 101.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 101.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 101.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 101.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 173.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 173.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 173.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 173.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3509.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2652; Denominator: 3509; Percentage: 75.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 857; Denominator: 3509; Percentage: 24.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1682; Denominator: 3509; Percentage: 47.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1827; Denominator: 3509; Percentage: 52.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2945; Denominator: 3394; Percentage: 86.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 115; Denominator: 3509; Percentage: 3.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 449; Denominator: 3394; Percentage: 13.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3900.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3796.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2814.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 982.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1580.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2216.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3331.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 90.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 375.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4500.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4329.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 3221.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1108.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1930; Denominator: 4329; Percentage: 44.58%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2399.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3792.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 201.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 336.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1250.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1147.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 866; Denominator: 1147; Percentage: 75.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 281; Denominator: 1147; Percentage: 24.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 489; Denominator: 1147; Percentage: 42.63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 658; Denominator: 1147; Percentage: 57.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1022; Denominator: 1101; Percentage: 92.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 46; Denominator: 1147; Percentage: 4.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 79; Denominator: 1101; Percentage: 7.18%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="93.55">
          <comment>
            <narrative>Numerator: 58; Denominator: 62.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="97.1">
            <comment>
              <narrative>Numerator: 67; Denominator: 69.</narrative>
            </comment>
          </target>
          <actual value="96.8">
            <comment>
              <narrative>Numerator: 91; Denominator: 94.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="97.1">
            <comment>
              <narrative>Numerator: 67; Denominator: 69.</narrative>
            </comment>
          </target>
          <actual value="97">
            <comment>
              <narrative>Numerator: 98; Denominator: 101.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="98.55">
            <comment>
              <narrative>Numerator: 68; Denominator: 69.</narrative>
            </comment>
          </target>
          <actual value="90.7">
            <comment>
              <narrative>Numerator: 97; Denominator: 107.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="98.55">
            <comment>
              <narrative>Numerator: 68; Denominator: 69.</narrative>
            </comment>
          </target>
          <actual value="97.1">
            <comment>
              <narrative>Numerator: 100; Denominator: 103.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="100">
          <comment>
            <narrative>Numerator: 173; Denominator: 173.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 236; Denominator: 236.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 449; Denominator: 449.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 313; Denominator: 313.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 371; Denominator: 375.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 369; Denominator: 369.</narrative>
            </comment>
          </target>
          <actual value="99.4">
            <comment>
              <narrative>Numerator: 334; Denominator: 336.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 103; Denominator: 103.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="95.42">
          <comment>
            <narrative>Numerator: 2106; Denominator: 2207.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 2880; Denominator: 3000.</narrative>
            </comment>
          </target>
          <actual value="96.7">
            <comment>
              <narrative>Numerator: 3394; Denominator: 3509.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3822; Denominator: 3900.</narrative>
            </comment>
          </target>
          <actual value="97.6">
            <comment>
              <narrative>Numerator: 3706; Denominator: 3796.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4500; Denominator: 4500.</narrative>
            </comment>
          </target>
          <actual value="95.4">
            <comment>
              <narrative>Numerator: 4128; Denominator: 4329.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1250; Denominator: 1250.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 1101; Denominator: 1147.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QPA-T-IGAD-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis ("TB") interventions among refugees in Eastern Africa - Eastern Africa - Multicountry Eastern Africa IGAD (01-Apr-2022-31-Mar-2025)</narrative>
    </title>
    <description type="1">
      <narrative>Multicountry Eastern Africa IGAD, Tuberculosis, Intergovernmental Authority on Development</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To contribute to ending TB in the region by 2030. Objectives: To Strengthen capacity for TB and MDR-TB diagnosis and TB (TB/HIV) service provision in refugee camps including cross border health facilities; To strengthen in-country and cros border collaboration of NTPs/NAPs for improved TB (and TB/HIV) service provision among refugees; To address policy barriers and related national support to TB and MDR-TB services for refugees in the region.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="40000">
      <narrative>Intergovernmental Authority on Development</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="40000">
      <narrative>Intergovernmental Authority on Development</narrative>
    </participating-org>
    <other-identifier ref="QPA-T-IGADP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-04-01" />
    <activity-date type="2" iso-date="2022-04-01" />
    <activity-date type="3" iso-date="2025-03-31" />
    <activity-date type="4" iso-date="2025-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>George Sakvarelidze</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>george.sakvarelidze@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="3" />
    <recipient-region code="MCIGAD" vocabulary="99" vocabulary-uri="https://fetch.theglobalfund.org/v5/odata/geographies" percentage="100">
      <narrative>Multicountry Eastern Africa IGAD</narrative>
    </recipient-region>
    <sector vocabulary="1" code="12263" percentage="50.83">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="49.17">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="37.29">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.36">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="1a0e253d-91c8-4657-9773-7b54dc8e3409" percentage="10.52">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service organization and facility management</narrative>
        </description>
      </budget-item>
      <budget-item code="0c56da86-a109-475c-888b-db26ea3235a8" percentage="4.46">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="46.37">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">2124127.22</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">1750474.90</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">2123422.40</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">431975.00</value>
    </budget>
    <capital-spend percentage="0" />
    <transaction ref="a74d23af-ac3c-48a9-b2d3-b04ca169b475">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-03" />
      <value currency="USD" value-date="2022-05-03">2150372.00</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2511cc24-7f49-42ac-ad01-b522aa05eb70">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-05" />
      <value currency="USD" value-date="2022-05-05">263499.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="089ddfc5-182b-4018-ba0d-9d4d2a371cc7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">157509.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e32c9dd-6682-460c-9154-39525db1e04b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">345916.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e8e6d5ad-81b9-4dc0-9b44-d7c7fb783c8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">438401.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d7b74a68-2ef8-441b-8734-76408d47bfc0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">276218.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c074f4ff-cedd-4338-a650-21c630b22a2e">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-20" />
      <value currency="USD" value-date="2022-10-20">482442.07</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="05327a42-173c-4a8b-ba12-123ec80f4597">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-29" />
      <value currency="USD" value-date="2022-10-29">561717.66</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d4613612-c4d3-4dcf-96f7-6d5924229562">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-29" />
      <value currency="USD" value-date="2022-10-29">-482442.07</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b6ad7023-e909-4a8d-a27d-20c5cd02df9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">69331.10</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6fa15569-7098-4a41-b1d3-23b1c996bc7c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-13" />
      <value currency="USD" value-date="2022-12-13">25309.62</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e8064045-b480-4477-8689-01f5af3b0df2">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-13" />
      <value currency="USD" value-date="2022-12-13">14515.81</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b476db10-2cee-452e-99fb-d87b20407b27">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-10" />
      <value currency="USD" value-date="2023-01-10">268658.63</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0969c75b-82e2-4541-8594-b80e0b146cdc">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-02" />
      <value currency="USD" value-date="2023-02-02">536908.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c215ccff-ed5c-4a9e-a475-030ed958a66b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-02" />
      <value currency="USD" value-date="2023-02-02">18000.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7fa2a050-928e-448d-9ce6-e9dc3370a912">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-02" />
      <value currency="USD" value-date="2023-02-02">106738.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="da973758-d94b-413b-b63f-530bb4d7732c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-07" />
      <value currency="USD" value-date="2023-02-07">74719.26</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b163c79e-53f7-41b2-9c9e-db778b767a3a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-19" />
      <value currency="USD" value-date="2023-02-19">100316.25</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7f8e0c90-fd7b-43eb-8c0c-36f57daa1d74">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-19" />
      <value currency="USD" value-date="2023-02-19">-109183.24</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="474455f6-1e60-42a6-b37d-46babbba1b2c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-01" />
      <value currency="USD" value-date="2023-03-01">67903.05</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6b2bd16b-47cc-4361-b5ee-c5e3b609e695">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-12" />
      <value currency="USD" value-date="2023-03-12">-32413.20</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="79a01e08-d984-45bd-8636-e6209edb8de3">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-12" />
      <value currency="USD" value-date="2023-03-12">9056.03</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5b53185c-4e6e-4ca7-945a-a2710c11d678">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-24" />
      <value currency="USD" value-date="2023-04-24">4499.70</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d7c21ef-ae13-4df8-b6a5-adab81d7ca39">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-24" />
      <value currency="USD" value-date="2023-04-24">-9056.03</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="46eda93a-591a-43ef-8537-3cd10396fd21">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-08" />
      <value currency="USD" value-date="2023-05-08">-4499.70</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d397168-1ff6-46b7-b72c-8c34e14286b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-15" />
      <value currency="USD" value-date="2023-06-15">193650.00</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f185e9c-d55f-4b48-9cab-af8194eebc89">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-15" />
      <value currency="USD" value-date="2023-06-15">-7183.00</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f212086d-76ed-4ad2-9449-2d7cc2d20640">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">147957.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c13d9804-7d24-4471-ad50-7d046d3687ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">27693.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6517c97-8460-4d70-80e5-5252376d410b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">18000.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9e5090f1-4031-4ec1-adb0-0bd106c075af">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-23" />
      <value currency="USD" value-date="2023-09-23">2074353.91</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2797bb81-8d26-44b6-93c7-8b349899edf9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-26" />
      <value currency="USD" value-date="2023-09-26">106737.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c2754f73-ff9a-4fd6-b6d5-2a4a4779b4bd">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-26" />
      <value currency="USD" value-date="2023-09-26">29961.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a3e594ff-f292-4c93-bb88-4190d8b6463e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-26" />
      <value currency="USD" value-date="2023-09-26">245393.92</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d54f94a0-5eb8-4568-8b53-cf37d52294c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-05" />
      <value currency="USD" value-date="2023-12-05">6039.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29a96576-6c39-4d7c-ab77-55bb64154d40">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-05" />
      <value currency="USD" value-date="2023-12-05">126537.24</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40afb210-9595-468d-b2c0-082d93455a6b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-05" />
      <value currency="USD" value-date="2023-12-05">358500.22</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a7bf8f35-5b2b-43e9-862b-283d8b538174">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">150880.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="48eb0a62-e69c-4794-af8f-20cb0bda1026">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">252955.53</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="000a1b37-5abf-47e2-b189-4d7ac5fe65fa">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-09" />
      <value currency="USD" value-date="2024-04-09">287371.65</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="62b3d034-0f66-4c62-b2e6-2de1ef419123">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-09" />
      <value currency="USD" value-date="2024-04-09">106737.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31f586fd-5e9a-41da-9655-929dd09353b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-03" />
      <value currency="USD" value-date="2024-07-03">886539.17</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c26c376d-d054-462c-84c8-46d7bd569ed5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-03" />
      <value currency="USD" value-date="2024-07-03">-403241.35</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e801c8a9-70a1-49be-b23b-fd86c7cedd8b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-09" />
      <value currency="USD" value-date="2024-07-09">566544.17</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="343ed798-af14-48f2-9de0-b0ea0a588ceb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-09" />
      <value currency="USD" value-date="2024-07-09">319995.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0845116d-96d7-484c-8929-23aa0cb7b683">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">853302.80</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8eaa801b-85de-4b55-938d-eb3bed40b9a9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-05" />
      <value currency="USD" value-date="2024-11-05">146955.18</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5dbe2325-3f78-4baf-904f-fd782557b330">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-05" />
      <value currency="USD" value-date="2024-11-05">118406.47</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2b2b0ce6-2659-461f-a61c-c1ce820846c6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-30" />
      <value currency="USD" value-date="2025-01-30">420840.90</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cc927609-0e79-4a01-943e-88f79808f708">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">106737.00</value>
      <description>
        <narrative>Global Fund disbursement to QPA-T-IGADP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="babbae34-7502-4427-b09e-4e8cb7135221">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-16" />
      <value currency="USD" value-date="2026-04-16">-60363.25</value>
      <description>
        <narrative>Global Fund commitment to QPA-T-IGADP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="QPA-T-IGADP02-EXP-20230331">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-03-31" />
      <value currency="USD" value-date="2023-03-31">2423524.50</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP02, Apr 2022 to Mar 2023.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QPA-T-IGADP02-EXP-20240331">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-03-31" />
      <value currency="USD" value-date="2024-03-31">1873778.00</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP02, Apr 2023 to Mar 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QPA-T-IGADP02-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">2862952.00</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP02, Apr 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QPA-T-IGADP02-EXP-20250930">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-09-30" />
      <value currency="USD" value-date="2025-09-30">202788.00</value>
      <description>
        <narrative>Expenditure reported by Intergovernmental Authority on Development for QPA-T-IGADP02, Apr 2025 to Sep 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>Intergovernmental Authority on Development</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QPA-T-IGAD" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="27" />
        <baseline year="2020" iso-date="2020-12-31" value="25">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="2">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="20">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7">
          <dimension name="TB regimen" value="New TB drugs" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="20">
          <dimension name="TB regimen" value="Short regimens" />
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="40" />
          <actual value="33" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="40" />
          <actual value="29" />
          <actual value="28">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="1">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="9">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="20">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="2">
            <dimension name="TB regimen" value="New TB drugs" />
          </actual>
          <actual value="27">
            <dimension name="TB regimen" value="Short regimens" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="30" />
          <actual value="36" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="46.23">
          <comment>
            <narrative>Numerator: 1755; Denominator: 3796.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="71.8">
            <comment>
              <narrative>Numerator: 2872; Denominator: 4000.</narrative>
            </comment>
          </target>
          <actual value="51.7">
            <comment>
              <narrative>Numerator: 2612; Denominator: 5056.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="72">
            <comment>
              <narrative>Numerator: 2880; Denominator: 4000.</narrative>
            </comment>
          </target>
          <actual value="53.6">
            <comment>
              <narrative>Numerator: 2436; Denominator: 4548.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 3000; Denominator: 4000.</narrative>
            </comment>
          </target>
          <actual value="61.91">
            <comment>
              <narrative>Numerator: 2709; Denominator: 4376.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="1306" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="1400" />
          <actual value="1784" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="1440" />
          <actual value="1941" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="1500" />
          <actual value="1850" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="3796" />
        <baseline year="2020" iso-date="2020-12-31" value="2814">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="982">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="1929">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="1580">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="2216">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="3331">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="90">
          <dimension name="HIV test status" value="Not documented" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="375">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="4000" />
          <actual value="5056" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="4000" />
          <actual value="4548" />
          <actual value="3343">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="1205">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="2402">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="1904">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="2644">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="3934">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="191">
            <dimension name="HIV test status" value="Not documented" />
          </actual>
          <actual value="423">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="4000" />
          <actual value="4376" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="98.93">
          <comment>
            <narrative>Numerator: 371; Denominator: 375.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 392; Denominator: 392.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 477; Denominator: 484.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 396; Denominator: 396.</narrative>
            </comment>
          </target>
          <actual value="99.8">
            <comment>
              <narrative>Numerator: 422; Denominator: 423.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 400; Denominator: 400.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 341; Denominator: 341.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="97.63">
          <comment>
            <narrative>Numerator: 3706; Denominator: 3796.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="10.12">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 375; Denominator: 3706.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 3920; Denominator: 4000.</narrative>
            </comment>
          </target>
          <actual value="93.3">
            <comment>
              <narrative>Numerator: 4715; Denominator: 5056.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 3960; Denominator: 4000.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 4357; Denominator: 4548.</narrative>
            </comment>
          </actual>
          <actual value="9.71">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 423; Denominator: 4357.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 4000; Denominator: 4000.</narrative>
            </comment>
          </target>
          <actual value="98.19">
            <comment>
              <narrative>Numerator: 4297; Denominator: 4376.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>